D D Bigner

661 total citations
14 papers, 518 citations indexed

About

D D Bigner is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, D D Bigner has authored 14 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Oncology. Recurrent topics in D D Bigner's work include Glioma Diagnosis and Treatment (6 papers), DNA Repair Mechanisms (3 papers) and Cancer Research and Treatments (2 papers). D D Bigner is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), DNA Repair Mechanisms (3 papers) and Cancer Research and Treatments (2 papers). D D Bigner collaborates with scholars based in United States. D D Bigner's co-authors include Henry S. Friedman, A E Pegg, Stephen T. Keir, M E Dolan, Susan L. Marcelli, A H Friedman, R E McLendon, Ilkcan Cokgor, Demetrius M. Kokkinakis and M. Eileen Dolan and has published in prestigious journals such as Journal of Clinical Oncology, Journal of neurosurgery and Molecular Pharmacology.

In The Last Decade

D D Bigner

14 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D D Bigner United States	11	283	226	157	115	85	14	518
Sandra Ictech United States	9	184 0.7×	274 1.2×	102 0.6×	180 1.6×	70 0.8×	12	469
Lotte Hiddingh United States	8	214 0.8×	97 0.4×	203 1.3×	88 0.8×	109 1.3×	9	523
Andrew Capen United States	9	511 1.8×	121 0.5×	212 1.4×	99 0.9×	89 1.0×	19	724
Lucia Trandafir Switzerland	11	280 1.0×	73 0.3×	247 1.6×	272 2.4×	85 1.0×	22	634
Cathy E. Nolan United States	6	384 1.4×	113 0.5×	206 1.3×	61 0.5×	51 0.6×	8	585
Scott Ackler United States	8	472 1.7×	76 0.3×	233 1.5×	45 0.4×	38 0.4×	10	625
A. Cseh Austria	12	176 0.6×	128 0.6×	393 2.5×	401 3.5×	163 1.9×	39	604
Jianning Yang United States	14	320 1.1×	254 1.1×	220 1.4×	79 0.7×	43 0.5×	29	693
Carlos R. Gil Del Alcazar United States	7	247 0.9×	91 0.4×	205 1.3×	80 0.7×	109 1.3×	9	440
Hendrika M. Oosterkamp Netherlands	9	214 0.8×	63 0.3×	200 1.3×	52 0.5×	191 2.2×	26	441

Countries citing papers authored by D D Bigner

Since Specialization

Citations

This map shows the geographic impact of D D Bigner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D D Bigner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D D Bigner more than expected).

Fields of papers citing papers by D D Bigner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D D Bigner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D D Bigner. The network helps show where D D Bigner may publish in the future.

Co-authorship network of co-authors of D D Bigner

This figure shows the co-authorship network connecting the top 25 collaborators of D D Bigner. A scholar is included among the top collaborators of D D Bigner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D D Bigner. D D Bigner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Cui, Bo, et al.. (2009). Bifunctional DNA Alkylator 1,3-Bis(2-chloroethyl)-1-nitrosourea Activates the ATR-Chk1 Pathway Independently of the Mismatch Repair Pathway. Molecular Pharmacology. 75(6). 1356–1363. 27 indexed citations

Keir, Stephen T., et al.. (2000). O 6 -Benzylguanine-mediated enhancement of nitrosourea activity in Mer − central nervous system tumor xenografts - implications for clinical trials. Cancer Chemotherapy and Pharmacology. 45(6). 437–440. 14 indexed citations

Kuan, Chien‐Tsun, Craig J. Reist, Catherine Foulon, et al.. (1999). 125I-labeled anti-epidermal growth factor receptor-vIII single-chain Fv exhibits specific and high-level targeting of glioma xenografts.. PubMed. 5(6). 1539–49. 50 indexed citations

Sampson, John H., et al.. (1999). Treatment of neoplastic meningitis with intrathecal temozolomide.. PubMed. 5(5). 1183–8. 29 indexed citations

Friedman, H. S., Demetrius M. Kokkinakis, James M. Pluda, et al.. (1998). Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma.. Journal of Clinical Oncology. 16(11). 3570–3575. 160 indexed citations

Johnson, S P, Laura P. Hale, Jialin Li, et al.. (1998). Analysis of DNA mismatch repair proteins in human medulloblastoma.. PubMed. 4(6). 1415–9. 10 indexed citations

Friedman, Henry S., M E Dolan, A E Pegg, et al.. (1995). Activity of temozolomide in the treatment of central nervous system tumor xenografts.. PubMed. 55(13). 2853–7. 124 indexed citations

Kurpad, Shekar N., et al.. (1995). Intraarterial administration of melphalan for treatment of intracranial human glioma xenografts in athymic rats.. PubMed. 55(17). 3803–9. 7 indexed citations

Friedman, Henry S., et al.. (1993). Intraarterial therapy of human glioma xenografts in athymic rats using 4-hydroperoxycyclophosphamide.. PubMed. 53(10 Suppl). 2338–43. 18 indexed citations

10.

Groothuis, Dennis R., Bodo Lippitz, István Fekete, et al.. (1992). The effect of an amino acid-lowering diet on the rate of melphalan entry into brain and xenotransplanted glioma.. PubMed. 52(20). 5590–6. 15 indexed citations

11.

Elion, Gertrude B., S. Clifford Schold, Martin Blum, et al.. (1991). Therapeutic analysis of melphalan-resistant human rhabdomyosarcoma xenograft TE-671 MR.. PubMed. 51(15). 3906–9. 3 indexed citations

12.

Bigner, Sandra H., et al.. (1990). Successful laboratory growth and analysis of CUSA-obtained medulloblastoma samples. Journal of neurosurgery. 72(5). 821–823. 16 indexed citations

13.

Elion, Gertrude B., et al.. (1990). Synergistic interactions between cyclophosphamide or melphalan and VP-16 in a human rhabdomyosarcoma xenograft.. PubMed. 50(2). 284–7. 22 indexed citations

14.

Colvin, O. Michael, et al.. (1989). Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion.. PubMed. 49(24 Pt 1). 6917–22. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact